CH
Canton Hathaway’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
7,095
-1,750
| -20% | -$145K | 0.12% | 81 |
|
|
2025
Q1 | $717K | Sell |
8,845
-8,415
| -49% | -$682K | 0.14% | 66 |
|
|
2024
Q4 | $1.55M | Sell |
17,260
-1,685
| -9% | -$152K | 0.39% | 34 |
|
|
2024
Q3 | $1.87M | Buy |
18,945
+1,310
| +7% | +$129K | 0.47% | 29 |
|
|
2024
Q2 | $1.64M | Buy |
17,635
+4,060
| +30% | +$376K | 0.45% | 32 |
|
|
2024
Q1 | $1.29M | Buy |
+13,575
| New | +$1.29M | 0.35% | 37 |
|
|
2022
Q3 | – | Sell |
-300
| Closed | -$22K | – | 262 |
|
|
2022
Q2 | $22K | Buy |
+300
| New | +$22K | 0.01% | 242 |
|
|
2022
Q1 | – | Sell |
-300
| Closed | -$34K | – | 296 |
|
|
2021
Q4 | $34K | Sell |
300
-50
| -14% | -$5.67K | 0.01% | 226 |
|
|
2021
Q3 | $44K | Hold |
350
| – | – | 0.01% | 195 |
|
|
2021
Q2 | $47K | Hold |
350
| – | – | 0.01% | 166 |
|
|
2021
Q1 | $47K | Hold |
350
| – | – | 0.02% | 165 |
|
|
2020
Q4 | $49K | Hold |
350
| – | – | 0.02% | 169 |
|
|
2020
Q3 | $39K | Hold |
350
| – | – | 0.02% | 241 |
|
|
2020
Q2 | $39K | Hold |
350
| – | – | 0.03% | 114 |
|
|
2020
Q1 | $27K | Hold |
350
| – | – | 0.02% | 117 |
|
|
2019
Q4 | $33K | Hold |
350
| – | – | 0.02% | 147 |
|
|
2019
Q3 | $27K | Hold |
350
| – | – | 0.02% | 157 |
|
|
2019
Q2 | $31K | Hold |
350
| – | – | 0.02% | 151 |
|
|
2019
Q1 | $31K | Hold |
350
| – | – | 0.02% | 152 |
|
|
2018
Q4 | $25K | Hold |
350
| – | – | 0.02% | 133 |
|
|
2018
Q3 | $34K | Buy |
+350
| New | +$34K | 0.02% | 114 |
|